Lv752
5000 积分 2022-09-02 加入
温抗体型自身免疫性溶血性贫血诊疗进展
4天前
已完结
Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial
5天前
已完结
Diagnosis and management of Evans syndrome in adults: first consensus recommendations
7天前
已完结
Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy
9天前
已完结
Autoimmune Hemolytic Anemias
9天前
已完结
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi
9天前
已完结
Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study
10天前
已关闭
Real‐world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study
14天前
已完结
Clinical Impact of the Cell-of-Origin Classification and the MYC / BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
21天前
已关闭
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study
29天前
已完结
皖公网安备34019202002308
